Myasthenic Syndromes, Congenital
Information
- Disease name
- Myasthenic Syndromes, Congenital
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02562066 | Completed | Phase 3 | Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes | January 2016 | October 2019 |
| NCT01765140 | No longer available | Treatment Use of 3,4-Diaminopyridine | |||
| NCT00541216 | Unknown status | Phase 1/Phase 2 | Ephedrine for the Treatment of Congenital Myasthenia | October 2007 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020294